Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MAPK pathway activation abrogates CCR7-mediated migration and prolongs survival to trap dendritic cells in LCH lesions

ABSTRACT: MAPK pathway activation abrogates CCR7-mediated migration and prolongs survival to trap dendritic cells in LCH lesions

PROVIDER: PRJNA419472 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

MAPK pathway activation abrogates CCR7-mediated migration and prolongs survival to trap dendritic cells in LCH lesions

Project description:MAPK pathway activation abrogates CCR7-mediated migration and prolongs survival to trap dendritic cells in LCH lesions

| PRJNA419472 | ENA

MAPK pathway activation abrogates CCR7-mediated migration and prolongs survival to trap dendritic cells in LCH lesions

Project description:Patient lesion and control sorted cells were used, treatment with different inhibitors for MAPK pathways for desired amount of time and then was sorted for CD207 and was used for RNA followed by Cdna amplification and was subjected for gene expression analysis using Affy Chips

2017-11-23 | GSE107254 | GEO

Prenociceptin TRAP

Project description:Prenociceptin TRAP

| PRJNA428727 | ENA

Faecalibacterium prausnitzii abrogates immunotherapy toxicity

Project description:Faecalibacterium prausnitzii abrogates immunotherapy toxicity

| PRJNA932844 | ENA

TCR repertoire of effector CCR7-CD38+ cells accumulating during experimental infection with Typhoidal Salmonella

Project description:In order to characterize pathogen specific T cell responses against Salmonella volunteers challenged with Salmonella enterica serovar Typhi (S. Typhi) or Salmonella Paratyphi A (S. Paratyphi). we used mass cytometry, to identify effector CD4+ T cells circulating during infection. We identified a population of CCR7-CD38+ cells accumulating during infection, and via unbiased single cell cloning and expansion we demonstrated that these CCR7-CD38+ cells are enriched in Salmonella specific T cells. In this experiment we performed TCR repertoire analysis of CCR7-CD38+ and CCR7-CD38- cells to determine the clonality of CCR7-CD38+ cells, the overlap between the repertoire of CCR7-CD38+ cells and of non-activated effector CCR7-CD38- cells, and to identify within CCR7-CD38+ and CCR7-CD38- cells the presence of the CDR3b TCR sequence of the pathogen specific T cell clones isolated from CCR7-CD38+ cells

2018-05-13 | GSE113112 | GEO

VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Project description:This phase II trial is studying how well VEGF Trap works in treating patients with previously treated metastatic colorectal cancer. VEGF Trap may stop the growth of colorectal cancer by blocking blood flow to the tumor.

| 2035047 | ecrin-mdr-crc

Transcription profile of B cells isolated from peripheral lymph nodes of wild-type vs CCR7-/- mice

Project description:We investigated the transcriptional profile of B cells isolated from peripheral lymph nodes of CCR7-/-C57BL/6 and C57BL/6 mice respectively. B cells were sorted as follows: CD19+, CD3-, CD11c-, CD11b-, NK1.1-, GR-1-. Very few genes were differentially regulated in CCR7-/- B cells, however the expression of a number of genes associated with B-cell activation was increased in CCR7-/- B cells compared to WT B cells. Our data suggest a role of CCR7 signaling in B-cell activation processes. 12 purified RNA samples (6 samples of each genotype), originated from 12 individually facs-sorted cell samples, were used for the microarray study. 3 RNA samples per genotype were pooled, giving rise to 2 wildtype- and 2 Ccr7 knock-out pools. In each of the 2 dual-color microarray hybridizations, samples from 1 wildtype and 1 Ccr7 knock-out pool were cohybridized. Microarray hybridizations 1 and 2 were performed in a dye-swap approach.

2011-11-21 | E-GEOD-27885 | biostudies-arrayexpress

RNA-seq of glioblastoma stem cells treated by CCR7 inhibitors.

Project description:RNA-seq of glioblastoma stem cells treated by CCR7 inhibitors.

2023-08-04 | GSE218041 | GEO

RAF/MEK/extracellular signal–related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions

Project description:Expression data from dendritic cell subsets derived or sorted from control littermate and CD11c-Cre/BRAFV600E(flox-CA) mice Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia characterized by granulomatous lesions containing pathological CD207+ dendritic cells (DCs) with constitutively activated mitogen-activated protein kinase (MAPK) pathway signaling. Approximately 60% of LCH patients harbor somatic BRAFV600E mutations localizing to CD207+ DCs within lesions. However, the mechanisms driving BRAFV600E+ LCH cell accumulation in lesions remain unknown. Here we show that sustained extracellular signal–related kinase activity induced by BRAFV600E inhibits C-C motif chemokine receptor 7 (CCR7)–mediated DC migration, trapping DCs in tissue lesions. Additionally, BRAFV600E increases expression of BCL2-like protein 1 (BCL2L1) in DCs, resulting in resistance to apoptosis. Pharmacological MAPK inhibition restores migration and apoptosis potential in a mouse LCH model, as well as in primary human LCH cells. We also demonstrate that MEK inhibitor-loaded nanoparticles have the capacity to concentrate drug delivery to phagocytic cells, significantly reducing off-target toxicity. Collectively, our results indicate that MAPK tightly suppresses DC migration and augments DC survival, rendering DCs in LCH lesions trapped and resistant to cell death.

2017-12-20 | GSE108251 | GEO

RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

Project description:RNA-seq of glioblastoma stem cells with shRNA-mediated CCR7 knockdown

2023-08-04 | GSE218042 | GEO